Ayan Chanda
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Interleukin-33: A new frontier in cancer immunotherapy.
Journal: International review of cell and molecular biology
Published: May 20, 2026
VSV∆M51 drives CD8+ T cell-mediated tumour regression through infection of both cancer and non-cancer cells.
Journal: Nature communications
Published: October 11, 2023
ING1 inhibits Twist1 expression to block EMT and is antagonized by the HDAC inhibitor vorinostat.
Journal: European journal of cell biology
Published: March 21, 2023
Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response.
Journal: Nature communications
Published: October 31, 2022
Sumoylated SnoN interacts with HDAC1 and p300/CBP to regulate EMT-associated phenotypes in mammary organoids.
Journal: Cell death & disease
Published: August 18, 2022
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
Journal: Cancer gene therapy
Published: July 13, 2022
TGF-β Mediated Immune Evasion in Cancer-Spotlight on Cancer-Associated Fibroblasts.
Journal: Cancers
Published: September 30, 2020
Correction: PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Journal: Cell death and differentiation
Published: August 20, 2020
PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Journal: Cell death and differentiation
Published: February 18, 2020
Last Updated: 09/26/2026